Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 34

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 34
---
 SECURITIES.

Our common stock is listed on
The Nasdaq Global Market under the symbol “IXHL.” On November 4, 2024, the last reported sale price of our common stock on
The Nasdaq Global Market was $2.46 per share. On September 30, 2024, the date we filed our Annual Report on Form 10-K for the fiscal year
ended June 30, 2024, our prospectus became subject to the offering limits in General Instruction I.B.6 of Form S-3. As of the date hereof,
the aggregate market value of our common stock held by non-affiliates pursuant to General Instruction I.B.6 of Form S-3 is $30.59 million,
which was calculated based on 12,961,669 shares of our common stock outstanding held by non-affiliates and a price of $2.36 per share,
the closing price of our common stock on October 18, 2024. As of the date of this prospectus, we have not sold any securities pursuant
to General Instruction I.B.6 of Form S-3 during the 12 calendar months prior to, and including, the date of this prospectus. Pursuant
to General Instruction I.B.6 of Form S-3, in no event will we sell securities in public primary offerings on Form S-3 with a value exceeding
more than one-third of our public float (as defined by General Instruction I.B.6) in any 12 calendar month period so long as our public
float remains below $75 million.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is November 22, 2024.

TABLE OF CONTENTS</div>

| ABOUT THIS PROSPECTUS                                | ii |
| PROSPECTUS SUMMARY                                   |  1 |
| RISK FACTORS                                         |  3 |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS |  4 |
| USE OF PROCEEDS                                      |  6 |
| DIVIDEND POLICY                                      |  7 |
| DESCRIPTION OF CAPITAL STOCK                         |  8 |
| DESCRIPTION OF DEBT SECURITIES                       | 13 |
| DESCRIPTION OF WARRANTS                              | 19 |
| DESCRIPTION OF UNITS